Skip to main content
. 2013 Jan 4;15(1):R1. doi: 10.1186/ar4127

Figure 2.

Figure 2

Antibody levels for serotype 23F at vaccination, at 4to 6 weeks after vaccination, and at 1.5-year follow-up in patients with rheumatoid arthritis (RA) and spondyloarthropathy (SpA) treated with different antiinflammatory drugs. Antibody levels ≥1 mg/L were considered putative protective (short dashed line).